# Rubicon Research Limited (RUBICON.NS): MoatMap facts

As of 17 Oct 2026. Research data, not investment advice.

As of 17 Oct 2026, MoatMap's StockRank for Rubicon Research Limited (RUBICON.NS) is 71/100, ranked against 24,000+ stocks in 35 markets (Quality 72, Value 14, Momentum 80, each scored against its sector).

- StockRank: 71/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 72, Value 14, Momentum 80: each a 0-100 percentile within the stock's sector.
- Position: #7,713 overall, #800 in Healthcare.
- Listing: India, NSI; Healthcare / Drug Manufacturers - General.
- Last close: 1,477.1 INR on 15 Oct 2026.
- Insider filings, last 180 days: directors sold USD 263K; 5%+ holders sold USD 244.8M.

Source: https://moatmap.ai/stock/RUBICON.NS
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker